EAHAD 2022: HMB-001 A novel bispecific antibody with potential for subcutaneous prophylactic treatment of multiple bleeding disorders initial focus on Glanzmann Thrombasthenia (GT)

June 1, 2022
July 22, 2025

Presented at 15th Annual Congress of the European Association of Haemophilia and Allied Disorders

To view the presentation, click here